news_6

Australia Data Center Market Investment Analysis and Growth Opportunities Report 2021-2026: 106 Existing Facilities, 15 Upcoming Facilities & Coverage of 11 Cities – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Data Center Market - Investment Analysis and Growth Opportunities 2021-2026" report has been added to ResearchAndMarkets.com's offering....

news_6

India Defence Market Report 2021-2030: Privatisation Thrust and Geopolitical Situation Transforming the $300+ Billion Industry – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Privatisation Thrust and Geopolitical Situation Transforming the Indian Defence Market" report has been added to ResearchAndMarkets.com's offering. The...

news_6

BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Tislelizumab combined with chemotherapy demonstrated a statistically significant improvement in progression-free survival at the interim analysis Safety findings of tislelizumab...

news_6

Global Major Depressive Disorder Drugs Markets Report 2021: Duloxetine, Escitalopram & Venlafaxine – Focus on US, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, Brazil – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Major Depressive Disorder Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Product...

news_6

East Asia Semiconductor Market Report 2021-2025: Market is Poised to Grow by $84.41 Billion with South Korea Driving growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Semiconductor Market in East Asia 2021-2025" report has been added to ResearchAndMarkets.com's offering. The semiconductor market in East...

news_6

 U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment

news_6

CORRECTING and REPLACING Meiji Seika Pharma: Promising Results of Phase I Clinical Trial of DMB-3115, a Proposed Ustekinumab Biosimilar, and Initiation of Phase III Clinical Trial in Patients With Plaque Psoriasis